Status:
COMPLETED
Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With Leukemia
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Childhood Acute Lymphoblastic Leukemia
Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies
Eligibility:
All Genders
Up to 2 years
Brief Summary
This research study is studying lestaurtinib with or with chemotherapy in samples from young patients with leukemia. Studying the effects of lestaurtinib with or without chemotherapy in cell samples f...
Detailed Description
PRIMARY OBJECTIVES: I. Determine the potential of lestaurtinib with or without chemotherapy agents in treating samples from infants with leukemia. II. Determine whether FLT3 protein expression level...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Cryopreserved samples from infants with leukemia available
Exclusion
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01150669
Start Date
July 1 2010
End Date
May 1 2016
Last Update
May 18 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Oncology Group
Monrovia, California, United States, 91006-3776